7,554
Views
3
CrossRef citations to date
0
Altmetric
Articles

Cognitive behavioural group therapy for adolescents with ADHD: a study of satisfaction and feasibility

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 280-286 | Received 30 Mar 2021, Accepted 02 Aug 2021, Published online: 19 Aug 2021

References

  • Polanczyk G, de Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164(6):942–948.
  • Biederman J, Petty CR, Evans M, et al. How persistent is ADHD? A controlled 10-year follow-up study of boys with ADHD. Psychiatry Res. 2010;177(3):299–304.
  • Franke B, Michelini G, Asherson P, et al. Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan. Eur Neuropsychopharmacol. 2018;28(10):1059–1088.
  • Torgersen T, Gjervan B, Rasmussen K. ADHD in adults: a study of clinical characteristics, impairment and comorbidity. Nord J Psychiatry. 2006;60(1):38–43.
  • Du Rietz E, Jangmo A, Kuja-Halkola R, et al. Trajectories of healthcare utilization and costs of psychiatric and somatic multimorbidity in adults with childhood ADHD: a prospective register-based study. J Child Psychol Psychiatry. 2020;61(9):959–968.
  • Sciberras E, Streatfeild J, Ceccato T, et al. Social and economic costs of attention-deficit/hyperactivity disorder across the lifespan. J Atten Disord. 2020;1087054720961828. DOI: https://doi.org/10.1177/1087054720961828.
  • Helsedirektoratet. ADHD Nasjonal faglig retningslinje: Helsedirektoratet; 2016 [updated 06.2018. National guidlines]. Available from: https://www.helsedirektoratet.no/retningslinjer/adhd#!
  • NICE National Institute for Health and Care Excellence. The NICE guideline on diagnosis and management of ADHD in children, young people and adults: NICE; 2018. [updated 09.2019]. Available from: https://www.nice.org.uk/guidance/ng87.
  • Cortese S. Pharmacologic treatment of attention deficit-hyperactivity disorder. N Engl J Med. 2020;383(11):1050–1056.
  • Jangmo A, Stålhandske A, Chang Z, et al. Attention-deficit/hyperactivity disorder, school performance, and effect of medication. J Am Acad Child Adolesc Psychiatry. 2019;58(4):423–432.
  • Posner J, Polanczyk GV, Sonuga-Barke E. Attention-deficit hyperactivity disorder. The Lancet. 2020;395(10222):450–462.
  • Biederman J, Fried R, DiSalvo M, et al. Evidence of low adherence to stimulant medication among children and youths with ADHD: an electronic health records study. Psychiatr Serv. 2019;70(10):874–880.
  • Chan E, Fogler JM, Hammerness PG. Treatment of attention-deficit/hyperactivity disorder in adolescents: a systematic review. JAMA. 2016;315(18):1997–2008.
  • Oud M, de Winter L, Vermeulen-Smit E, et al. Effectiveness of CBT for children and adolescents with depression: a systematic review and meta-regression analysis. Eur Psychiatry. 2019;57:33–45.
  • Carpenter JK, Andrews LA, Witcraft SM, et al. Cognitive behavioral therapy for anxiety and related disorders: a meta-analysis of randomized placebo-controlled trials. Depress Anxiety. 2018;35(6):502–514.
  • Uhre CF, Uhre VF, Lønfeldt NN, et al. Systematic review and meta-analysis: cognitive-behavioral therapy for obsessive-compulsive disorder in children and adolescents. J Am Acad Child Adol Psychiat. 2020;59(1):64–77.
  • Young Z, Moghaddam N, Tickle A. The efficacy of cognitive behavioral therapy for adults with ADHD: a systematic review and meta-analysis of randomized controlled trials. J Atten Disord. 2020;24(6):875–888.
  • Boyer BE, Geurts HM, Prins PJ, et al. Two novel CBTs for adolescents with ADHD: the value of planning skills. Eur Child Adolesc Psychiatry. 2015;24(9):1075–1090.
  • Sprich SE, Safren SA, Finkelstein D, et al. A randomized controlled trial of cognitive behavioral therapy for ADHD in medication-treated adolescents. J Child Psychol Psychiatr. 2016;57(11):1218–1226.
  • Vidal R, Castells J, Richarte V, et al. Group therapy for adolescents with attention-deficit/hyperactivity disorder: a randomized controlled trial. J Am Acad Child Adol Psychiat. 2015;54(4):275–282.
  • Antshel KM, Faraone SV, Gordon M. Cognitive behavioral treatment outcomes in adolescent ADHD. J Atten Disord. 2014;18(6):483–495.
  • Geissler J, Jans T, Banaschewski T, et al. Individualised short-term therapy for adolescents impaired by attention-deficit/hyperactivity disorder despite previous routine care treatment (ESCAadol)-study protocol of a randomised controlled trial within the consortium ESCAlife. Trials. 2018;19(1):254.
  • Nøvik TS, Haugan AJ, Lydersen S, et al. Cognitive-behavioural group therapy for adolescents with ADHD: study protocol for a randomised controlled trial. BMJ Open. 2020;10(3):e032839.
  • Park J, Kim B. Comorbidity and factors affecting treatment non-persistence in ADHD. J Atten Disord. 2020;24(9):1276–1284.
  • Bukstein OG. Satisfaction with treatment for attention-deficit/hyperactivity disorder. Am J Manag Care. 2004;10(4 Suppl):S107–S16.
  • Black N. Patient reported outcome measures could help transform healthcare. BMJ. 2013;346:f167.
  • World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992.
  • Guy W. ECDEU assesment manual for psychopharmacology. Rockville, MD: US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs; 1976.
  • Young S, Bramham J. Cognitive-behavioural therapy for ADHD in adolescents and adults: a psychological guide to practice. 2nd ed. London, UK: John Wiley & Sons; 2012. p. 330.
  • Kaufman J, Birmaher B, Brent D, et al. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36(7):980–988.
  • DuPaul G, Power T, Anastopoulos A, et al. ADHD rating scale-5 for children and adolescents: checklists, norms, and clinical interpretation. New York: Guilford Press; 2016.
  • Döpfner M, ADORE Study Group, Steinhausen HC, Coghill D, Dalsgaard S, Poole L, Ralston SJ, et al. Cross-cultural reliability and validity of ADHD assessed by the ADHD rating scale in a pan-European study. Eur Child Adolesc Psychiatry. 2006;15(Suppl 1):I46–55.
  • Shaffer D, Gould MS, Brasic J, et al. A children's global assessment scale (CGAS). Arch Gen Psychiatry. 1983;40(11):1228–1231.
  • Jozefiak T, Hanssen-Bauer K, Bjelland I. Måleegenskaper ved den norske versjonen av childrens global assessment scale (CGAS). PsykTestBARN. 2018;1(3):1–14.
  • Bramham J, Young S, Bickerdike A, et al. Evaluation of group cognitive behavioral therapy for adults with ADHD. J Atten Disord. 2009;12(5):434–441.
  • Jensen CM, Steinhausen H-C. Comorbid mental disorders in children and adolescents with attention-deficit/hyperactivity disorder in a large nationwide study. Atten Defic Hyperact Disord. 2015;7(1):27–38.
  • Meyer J, Öster C, Ramklint M, et al. You are not alone - adolescents' experiences of participation in a structured skills training group for ADHD. Scand J Psychol. 2020;61(5):671–678.
  • LeBeau RT, Davies CD, Culver NC, et al. Homework compliance counts in cognitive-behavioral therapy. Cogn Behav Ther. 2013;42(3):171–179.
  • Schei J, Jozefiak T, Nøvik TS, et al. The impact of coexisting emotional and conduct problems on family functioning and quality of life among adolescents with ADHD. J Atten Disord. 2016;20(5):424–433.